Clinical Trial Update: Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating bone marrow mesenchymal stem cell transfer in patients with ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• bone marrow mesenchymal stem cells transfer

Snippet

Sponsor: Affiliated Hospital of North Sichuan Medical College | Conditions: Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED